Innovative Therapeutix, Inc. — Form D
Innovative Therapeutix, Inc. of LOUISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-02. The offering totals $600K, of which $170K was reported sold. Industry: Other.
Offering
- Filed: 2022-02-02
- Form: D
- Accession: 0001908403-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $600K
- Amount sold: $170K
- Remaining: $430K
- Investors: 7
- Date of first sale: 2021-12-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-431840
Issuer
- Name: Innovative Therapeutix, Inc.
- CIK: 0001908403
- Entity type: Corporation
- Jurisdiction: KENTUCKY
- Incorporated: 2017
- Address: 3032 NADINA DR., LOUISVILLE, KY, 40220
- Phone: (618) 974-8907
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Robert R Saunders | Director | Louisville, KY |
| Rebekah R Gossom | Director | Louisville, KY |
| Michael R Detmer | Director | Louisville, KY |
| Michael R Detmer | Executive Officer | Louisville, KY |
Other filings by this issuer (1)
More